Sagimet Biosciences (SGMT) Assets (2023 - 2024)
Sagimet Biosciences has reported Assets over the past 2 years, most recently at $174.8 million for Q3 2024.
- Quarterly results put Assets at $174.8 million for Q3 2024, up 69.81% from a year ago — trailing twelve months through Sep 2024 was $174.8 million (up 69.81% YoY), and the annual figure for FY2023 was $96.7 million, changed.
- Assets for Q3 2024 was $174.8 million at Sagimet Biosciences, down from $189.0 million in the prior quarter.
- Over the last five years, Assets for SGMT hit a ceiling of $194.5 million in Q1 2024 and a floor of $21.5 million in Q2 2023.